Prothena Corporation plc Stock News

Prothena (PRTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Eli Lilly stock reversed premarket gains at the open Tuesday after an FDA panel endorsed its Alzheimer's treatment, donanemab.

Prothena (PRTA) reported earnings 30 days ago. What's next for the stock?

Prothena (PRTA) announces that Bristol Myers is exercising its option for the second time, thereby in-licensing exclusive global rights for PRX019 to potentially treat neurodegenerative diseases.

DUBLIN--(BUSINESS WIRE)---- $PRTA #prothena--Prothena today announced that Bristol Myers Squibb obtained the exclusive global license for PRX019 and will pay Prothena $80 million.

Prothena (PRTA) posts a wider-than-expected loss in the first quarter on lower revenues and higher costs.

Prothena (PRTA) came out with a quarterly loss of $1.34 per share versus the Zacks Consensus Estimate of a loss of $1.21. This compares to loss of $0.89 per share a year ago.

Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DUBLIN--(BUSINESS WIRE)---- $PRTA #amyloidosis--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.

DUBLIN--(BUSINESS WIRE)---- $PRTA #prothena--Prothena today announced that members of its senior management team will participate in two upcoming investor conferences in March.

DUBLIN--(BUSINESS WIRE)---- $PRTA #prothena--Prothena today announced that it has named David Ford to a newly created position of Chief People Officer.

DUBLIN--(BUSINESS WIRE)---- $PRTA #prothena--Prothena announced today the appointment of Daniel G. Welch to its Board of Directors as an independent director and Chair Designate.

Prothena (PRTA) posts a wider-than-expected loss in the fourth quarter on lower revenues and higher costs.

Prothena Corporation plc (PRTA) Q4 2023 Earnings Call Transcript

DUBLIN--(BUSINESS WIRE)---- $PRTA #prothena--Prothena today reported financial results for the fourth quarter and full year 2023.